EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF APREMILAST
The invention relates to an extended release oral pharmaceutical composition comprising a core, wherein the core comprises apremilast or pharmaceutically acceptable salts, ester, solvates, polymorphs thereof, at least one extended release polymer and one or more pharmaceutically acceptable excipient...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | NARASIMHAM, P.V.S JAIN, Vivek SANGWAI, Rajeshwar KUMAR, Anil |
| description | The invention relates to an extended release oral pharmaceutical composition comprising a core, wherein the core comprises apremilast or pharmaceutically acceptable salts, ester, solvates, polymorphs thereof, at least one extended release polymer and one or more pharmaceutically acceptable excipients, wherein the core is optionally coated with a film coating composition. The composition of the invention can be used for the treatment of psoriasis, psoriatic arthritis.
La présente invention concerne une composition pharmaceutique orale à libération prolongée comprenant un noyau, le noyau comprenant de l'aprémilast ou des sels, esters, solvates pharmaceutiquement acceptables, polymorphes de celui-ci, au moins un polymère à libération prolongée et un ou plusieurs excipients pharmaceutiquement acceptables, le noyau étant facultativement enrobé avec une composition de revêtement de film. La composition de l'invention peut être utilisée pour le traitement du psoriasis et du rhumatisme psoriasique. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2019073477A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2019073477A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2019073477A13</originalsourceid><addsrcrecordid>eNrjZLB0jQhx9XNxdVEIcvVxdQx2VQjwcAzydXR2DQ3xdHb0UXD29w3wD_YM8fT3U_B3U3AMCHL19fRxDA7hYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBoaWBubGJubmjobGxKkCAEfVKfA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF APREMILAST</title><source>esp@cenet</source><creator>NARASIMHAM, P.V.S ; JAIN, Vivek ; SANGWAI, Rajeshwar ; KUMAR, Anil</creator><creatorcontrib>NARASIMHAM, P.V.S ; JAIN, Vivek ; SANGWAI, Rajeshwar ; KUMAR, Anil</creatorcontrib><description>The invention relates to an extended release oral pharmaceutical composition comprising a core, wherein the core comprises apremilast or pharmaceutically acceptable salts, ester, solvates, polymorphs thereof, at least one extended release polymer and one or more pharmaceutically acceptable excipients, wherein the core is optionally coated with a film coating composition. The composition of the invention can be used for the treatment of psoriasis, psoriatic arthritis.
La présente invention concerne une composition pharmaceutique orale à libération prolongée comprenant un noyau, le noyau comprenant de l'aprémilast ou des sels, esters, solvates pharmaceutiquement acceptables, polymorphes de celui-ci, au moins un polymère à libération prolongée et un ou plusieurs excipients pharmaceutiquement acceptables, le noyau étant facultativement enrobé avec une composition de revêtement de film. La composition de l'invention peut être utilisée pour le traitement du psoriasis et du rhumatisme psoriasique.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190418&DB=EPODOC&CC=WO&NR=2019073477A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190418&DB=EPODOC&CC=WO&NR=2019073477A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NARASIMHAM, P.V.S</creatorcontrib><creatorcontrib>JAIN, Vivek</creatorcontrib><creatorcontrib>SANGWAI, Rajeshwar</creatorcontrib><creatorcontrib>KUMAR, Anil</creatorcontrib><title>EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF APREMILAST</title><description>The invention relates to an extended release oral pharmaceutical composition comprising a core, wherein the core comprises apremilast or pharmaceutically acceptable salts, ester, solvates, polymorphs thereof, at least one extended release polymer and one or more pharmaceutically acceptable excipients, wherein the core is optionally coated with a film coating composition. The composition of the invention can be used for the treatment of psoriasis, psoriatic arthritis.
La présente invention concerne une composition pharmaceutique orale à libération prolongée comprenant un noyau, le noyau comprenant de l'aprémilast ou des sels, esters, solvates pharmaceutiquement acceptables, polymorphes de celui-ci, au moins un polymère à libération prolongée et un ou plusieurs excipients pharmaceutiquement acceptables, le noyau étant facultativement enrobé avec une composition de revêtement de film. La composition de l'invention peut être utilisée pour le traitement du psoriasis et du rhumatisme psoriasique.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB0jQhx9XNxdVEIcvVxdQx2VQjwcAzydXR2DQ3xdHb0UXD29w3wD_YM8fT3U_B3U3AMCHL19fRxDA7hYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBoaWBubGJubmjobGxKkCAEfVKfA</recordid><startdate>20190418</startdate><enddate>20190418</enddate><creator>NARASIMHAM, P.V.S</creator><creator>JAIN, Vivek</creator><creator>SANGWAI, Rajeshwar</creator><creator>KUMAR, Anil</creator><scope>EVB</scope></search><sort><creationdate>20190418</creationdate><title>EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF APREMILAST</title><author>NARASIMHAM, P.V.S ; JAIN, Vivek ; SANGWAI, Rajeshwar ; KUMAR, Anil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2019073477A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>NARASIMHAM, P.V.S</creatorcontrib><creatorcontrib>JAIN, Vivek</creatorcontrib><creatorcontrib>SANGWAI, Rajeshwar</creatorcontrib><creatorcontrib>KUMAR, Anil</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NARASIMHAM, P.V.S</au><au>JAIN, Vivek</au><au>SANGWAI, Rajeshwar</au><au>KUMAR, Anil</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF APREMILAST</title><date>2019-04-18</date><risdate>2019</risdate><abstract>The invention relates to an extended release oral pharmaceutical composition comprising a core, wherein the core comprises apremilast or pharmaceutically acceptable salts, ester, solvates, polymorphs thereof, at least one extended release polymer and one or more pharmaceutically acceptable excipients, wherein the core is optionally coated with a film coating composition. The composition of the invention can be used for the treatment of psoriasis, psoriatic arthritis.
La présente invention concerne une composition pharmaceutique orale à libération prolongée comprenant un noyau, le noyau comprenant de l'aprémilast ou des sels, esters, solvates pharmaceutiquement acceptables, polymorphes de celui-ci, au moins un polymère à libération prolongée et un ou plusieurs excipients pharmaceutiquement acceptables, le noyau étant facultativement enrobé avec une composition de revêtement de film. La composition de l'invention peut être utilisée pour le traitement du psoriasis et du rhumatisme psoriasique.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2019073477A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF APREMILAST |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A19%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NARASIMHAM,%20P.V.S&rft.date=2019-04-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2019073477A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |